Snowball logo
logo
DVLA_logo

Darya-Varia Laboratoria Tbk

DVLA JK
Rp1,580.00-Rp5.00  (0.32%)
Estimate
P/E
12.9
EPS
122.05
Beta
-0.092
Growth
Revenue, YoY
13.29%
Net income, YoY
-9.78%
FCF, YoY
-95.15%
Dividends
Dividend yield
8.1%
Annual payout
Rp128.00
Next ex. div date
December 30, 26
Payout
88.79%
Div.growth, 5y
0.19%
Div.rating
About the company
Ticker
DVLA
ISIN
ID1000117203
Country
Indonesia
Sector (GICS)
Healthcare
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Consumer Health Products, Prescription Drugs, Export & Toll Manufacturing, and Services. The company offers consumer health products, including skin nutrition products under the Natur-E brand; respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brands for nasal congestion, cough, and breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. It also provides prescription products for various therapeutic areas, including cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. In addition, the company offers toll manufacturing services for soft gelatin capsules, as well as sterile injections and low volume solid products. It also exports its products. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk operates as a subsidiary of Blue Sphere Singapore Pte. Ltd.

Frequently asked questions

What sector does Darya-Varia Laboratoria Tbk (DVLA) operate in?

Darya-Varia Laboratoria Tbk belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Darya-Varia Laboratoria Tbk (DVLA) current stock price?

As of the latest data, Darya-Varia Laboratoria Tbk stock price is IDR 1,580, with a previous close of IDR 1,585. Darya-Varia Laboratoria Tbk lost -IDR 5 in the last trading session, representing a -0.32% loss.

What is Darya-Varia Laboratoria Tbk (DVLA) current market capitalization?

Darya-Varia Laboratoria Tbk market cap is approximately 1.77 trillion.

What is Darya-Varia Laboratoria Tbk (DVLA) Earnings Per Share (EPS)?

The trailing EPS is IDR 122.

What is Darya-Varia Laboratoria Tbk (DVLA) Price-to-Earnings (P/E) ratio?

Darya-Varia Laboratoria Tbk current P/E ratio is 12.95.

What is Darya-Varia Laboratoria Tbk (DVLA) EBITDA?

Darya-Varia Laboratoria Tbk EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 66.26 billion.

Does Darya-Varia Laboratoria Tbk (DVLA) pay dividends?

Yes. Darya-Varia Laboratoria Tbk pays semiannual dividends with an annualized yield of 8.1% and an estimated annual payout of IDR 128 per share.

When is the next ex-dividend date for Darya-Varia Laboratoria Tbk (DVLA)?

The next ex-dividend date is scheduled for December 30, 2026.

What is Darya-Varia Laboratoria Tbk (DVLA) beta (volatility) score?

Darya-Varia Laboratoria Tbk has a beta of -0.092, indicating lower volatility than the overall market.